301263 Stock Overview
Guangdong Taienkang Pharmaceutical Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 1/6 |
My Notes
Capture your thoughts, links and company narrative
Guangdong Taienkang Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥15.83 |
| 52 Week High | CN¥17.03 |
| 52 Week Low | CN¥11.65 |
| Beta | -0.091 |
| 1 Month Change | 10.70% |
| 3 Month Change | 28.91% |
| 1 Year Change | -4.00% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -18.45% |
Recent News & Updates
Here's Why Guangdong Taienkang Pharmaceutical (SZSE:301263) Has A Meaningful Debt Burden
Nov 20
Weak Statutory Earnings May Not Tell The Whole Story For Guangdong Taienkang Pharmaceutical (SZSE:301263)
Sep 03Recent updates
Here's Why Guangdong Taienkang Pharmaceutical (SZSE:301263) Has A Meaningful Debt Burden
Nov 20Weak Statutory Earnings May Not Tell The Whole Story For Guangdong Taienkang Pharmaceutical (SZSE:301263)
Sep 03Guangdong Taienkang Pharmaceutical Co., Ltd.'s (SZSE:301263) P/E Still Appears To Be Reasonable
Aug 23Here's Why Guangdong Taienkang Pharmaceutical (SZSE:301263) Can Manage Its Debt Responsibly
Jul 22Guangdong Taienkang Pharmaceutical (SZSE:301263) Is Paying Out Less In Dividends Than Last Year
May 22Guangdong Taienkang Pharmaceutical (SZSE:301263) Seems To Use Debt Quite Sensibly
Feb 26Shareholder Returns
| 301263 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 2.6% | -4.3% | -3.5% |
| 1Y | -4.0% | -3.4% | 10.9% |
Return vs Industry: 301263 matched the CN Pharmaceuticals industry which returned -3.4% over the past year.
Return vs Market: 301263 underperformed the CN Market which returned 10.9% over the past year.
Price Volatility
| 301263 volatility | |
|---|---|
| 301263 Average Weekly Movement | 6.9% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 301263 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 301263's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 931 | Hanjie Zheng | www.tai-kang.com.cn |
Guangdong Taienkang Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China and internationally. The company provides products covering various therapeutic areas, including gender health medicines, ophthalmic medicines, gastrointestinal medicines, Chinese patent medicines and external medicines, and sanitary materials in the forms of tablets, pills, injections, and essential oils; medical technology and technology transfer services; and medical devices. It also operates as an agent for pharmaceutical products; and offers medical and daily cotton swabs, masks, sutures, surgical staplers, vascular clips and clip appliers, etc., as well as non-prescription drugs.
Guangdong Taienkang Pharmaceutical Co., Ltd. Fundamentals Summary
| 301263 fundamental statistics | |
|---|---|
| Market cap | CN¥6.70b |
| Earnings (TTM) | CN¥134.71m |
| Revenue (TTM) | CN¥752.06m |
49.8x
P/E Ratio8.9x
P/S RatioIs 301263 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301263 income statement (TTM) | |
|---|---|
| Revenue | CN¥752.06m |
| Cost of Revenue | CN¥306.87m |
| Gross Profit | CN¥445.19m |
| Other Expenses | CN¥310.48m |
| Earnings | CN¥134.71m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.32 |
| Gross Margin | 59.20% |
| Net Profit Margin | 17.91% |
| Debt/Equity Ratio | 14.0% |
How did 301263 perform over the long term?
See historical performance and comparisonDividends
1.9%
Current Dividend Yield94%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 01:17 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Guangdong Taienkang Pharmaceutical Co., Ltd. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Chaoze Zhou | Minsheng Securities Co. |
| Song Yang | Tianfeng Securities Brokerage Co., Ltd |
| Tielin Chen | Topsperity Securities |